Neapharma
The computed 12-month bankruptcy probability of Neapharma is 1.1% (low). The company has been active since 2015 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
| Active | 11 yrs |
| Locations | 2 |
| Publications | 1 |
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
| Fiscal year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2024 | micro | 25-07-2025 | 2025-00307589 |
| 31-12-2023 | micro | 07-08-2024 | 2024-00336485 |
| 31-12-2022 | micro | 28-07-2023 | 2023-00285231 |
| 31-12-2021 | micro | 01-08-2022 | 2022-20253773 |
| 31-12-2020 | micro | 25-06-2021 | 2021-28100569 |
| 31-12-2019 | micro | 31-08-2020 | 2020-48900310 |
| 31-12-2018 | micro | 02-08-2019 | 2019-43500250 |
| 31-12-2017 | micro | 17-08-2018 | 2018-47200034 |
| 31-12-2016 | verkort | 07-08-2017 | 2017-42300105 |
| NACE primary | Retail trade(47279) |
| Legal form | Private limited company(610) |
| Incorporation | 22-06-2015 |
| Status | Active |
| Postal code | 9550 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 45023A1469/00F000 | Flanders | 8,006 m² | 1 · 2,238 m² | - |
| 41028B0478/00F002 | Flanders | 540 m² | 1 · 327 m² | 9.8 m · 2 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
05-12-2023 Publication in the Belgian Official Gazette, Minor change
Technical details
{
"notary": {
"name": "Ivan Schaubroeck",
"firm_city": null,
"firm_name": null,
"office_city": "Oosterzele",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2023-12-05",
"filing_date": "2023-12-01",
"act_kind_objet": "ONTSLAGEN, BENOEMINGEN, STATUTEN (VERTALING, COORDINATIE, OVERIGE WIJZIGINGEN), WIJZIGING RECHTSVORM"
},
"decision": {
"body": "algemene_vergadering",
"date": "2023-11-30",
"unanimous": true
},
"agm_change": {
"new_schedule": "de laatste vrijdag van de maand juni om achttien uur (18u)",
"old_schedule": null,
"effective_from_year": null,
"rule_changes_summary": null
},
"detected_kind": "statutes_change",
"other_address": null,
"mandate_renewal": {
"period_end": null,
"mandate_kind": "bestuurder",
"period_start": null,
"remuneration_eur": null,
"remuneration_kind": null,
"person_or_entity_kbo": null,
"person_or_entity_name": "Kristof De Kegel"
},
"subject_company": {
"kbo": "0632.635.978",
"name_full": "Neapharma",
"legal_form": "BV"
},
"accounts_deposit": null,
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null
},
"co_filed_documents": [
"de uitgifte van de akte",
"geco\u00F6rdineerde statuten"
],
"fiscal_year_change": {
"new_end_mm_dd": "31",
"old_end_mm_dd": null,
"new_start_mm_dd": "01",
"old_start_mm_dd": null,
"first_full_new_year": null,
"transition_period_end": null
},
"liquidation_closure": null,
"officer_designation": null,
"special_procuration": {
"grantee_kbo": null,
"grantee_name": null,
"grantor_name": null,
"scope_summary": null,
"monetary_cap_eur": null,
"scope_categories": [],
"termination_clause": null,
"substitution_allowed": true
},
"is_volet_a_only_stub": false,
"vakbekwaamheid_change": null,
"should_reroute_to_category": null,
"single_shareholder_declaration": null
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | Neapharma |